SS
Surapaneni Sarojinidevi
About Surapaneni Sarojinidevi
Data last updated:
Surapaneni Sarojinidevi is a Whole-Time Director at Satyadeeptha Pharmaceuticals Limited (since 1999). The company operates in Pharma. Satyadeeptha Pharmaceuticals Limited reported revenue of ₹139 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Whole-Time Director | 20 Mar 1999 | 1987 | ₹139 Cr (FY 2025) | Active |
Board colleagues of Surapaneni Sarojinidevi
| Name | DIN | Company | Designation |
|---|---|---|---|
| Mandapakala Neelalohita | 11195797 | Satyadeeptha Pharmaceuticals Limited | Director |
| Prasada Rao Kalluri | 07780628 | Satyadeeptha Pharmaceuticals Limited | Director |
| Sudheer Kumar Aleti | 10655300 | Satyadeeptha Pharmaceuticals Limited | Director |
| Surapaneni Janardhana Rao | 08367143 | Satyadeeptha Pharmaceuticals Limited | Whole-Time Director |
| Surapaneni Ramakrishna | 00414395 | Satyadeeptha Pharmaceuticals Limited | Managing Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Surapaneni Sarojinidevi
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Surapaneni Sarojinidevi
Surapaneni Sarojinidevi currently holds 1 directorship: Satyadeeptha Pharmaceuticals Limited (Whole-Time Director, since 20 Mar 1999, revenue ₹139 Cr (FY 2025)).
Surapaneni Sarojinidevi was first appointed on 20 Mar 1999 as Whole-Time Director at Satyadeeptha Pharmaceuticals Limited.
The current boards of Surapaneni Sarojinidevi's companies include Mandapakala Neelalohita (Satyadeeptha Pharmaceuticals Limited), Prasada Rao Kalluri (Satyadeeptha Pharmaceuticals Limited), Sudheer Kumar Aleti (Satyadeeptha Pharmaceuticals Limited), Surapaneni Janardhana Rao (Satyadeeptha Pharmaceuticals Limited), Surapaneni Ramakrishna (Satyadeeptha Pharmaceuticals Limited).